4//SEC Filing
Reitan Colleen F 4
Accession 0001735276-25-000062
CIK 0001178670other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 4:05 PM ET
Size
11.6 KB
Accession
0001735276-25-000062
Insider Transaction Report
Form 4
Reitan Colleen F
Director
Transactions
- Purchase
Common Stock
2024-08-29$286.00/sh+32$9,152→ 32 total - Purchase
Common Stock
2024-10-17$302.67/sh+4$1,211→ 36 total - Sale
Common Stock
2025-04-16$232.86/sh−36$8,383→ 0 total - Award
Common Stock
2025-05-08+775→ 775 total - Award
Stock Option (right to buy)
2025-05-08+1,558→ 1,558 totalExercise: $258.35From: 2026-05-08Exp: 2035-05-08→ Common Stock (1,558 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
- [F2]The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
Related Parties
1- filerCIK 0001740730
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 4:05 PM ET
- Size
- 11.6 KB